Invention Grant
- Patent Title: Translational dysfunction based therapeutics
- Patent Title (中): 基于翻译功能障碍的疗法
-
Application No.: US12163449Application Date: 2008-06-27
-
Publication No.: US08497292B2Publication Date: 2013-07-30
- Inventor: Gordon A. Jamieson, Jr. , Katherine L. B. Borden , Biljana Culjkovic , Alex Kentsis
- Applicant: Gordon A. Jamieson, Jr. , Katherine L. B. Borden , Biljana Culjkovic , Alex Kentsis
- Applicant Address: US MA Arlington
- Assignee: Translational Therapeutics, Inc.
- Current Assignee: Translational Therapeutics, Inc.
- Current Assignee Address: US MA Arlington
- Agency: Foley Hoag LLP
- Main IPC: A61K31/4025
- IPC: A61K31/4025 ; C07D405/04
Abstract:
Provided are methods and compositions for inhibiting eukaryotic translation initiation factor. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer.
Public/Granted literature
- US20090163564A1 Translational Dysfunction Based Therapeutics Public/Granted day:2009-06-25
Information query
IPC分类:
